Company / EPS (Diluted)
Viatris EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.05
FY2025
5-year range
-$1.11 / $1.71
FY2021-FY2025
Trend
-97.1%
vs FY2024
Sector context
#47 of 204
Health Care
What the data says
Viatris's eps (diluted) of $0.05 is higher than 77% of companies in the Health Care sector (FY2025). Improved from $-1.05 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -40.7%. Top quartile in the Health Care sector.
Improved from $-1.05 to $0.05 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -40.7%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 204This company $0.05 Sector average -$0.89
▼
+105.6% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 97.1% year-over-year.
- Ranks #47 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -97.1% |
| FY2024 | $1.71 | +262.9% |
| FY2023 | -$1.05 | +5.4% |
| FY2022 | -$1.11 | -3800.0% |
| FY2021 | $0.03 | -95.6% |
| FY2020 | $0.68 | - |
| FY2019 | - | - |
| FY2018 | $0.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026